BoniEElewskiMD

Dermatology • Birmingham, AL

Professor, Dermatology, University of Alabama School of Medicine

Join to view full profile

Dr. Elewski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Elewski's full profile

Already have an account?

Office
500 22nd St S
Birmingham, AL 35233
Phone+1 205-996-7546
Is this information wrong?

Summary

Dr. Boni Elewski is a dermatologist in Birmingham, AL and is affiliated with multiple hospitals in the area, including Birmingham Veterans Affairs Medical Center and University of Alabama Hospital. She received her medical degree from The Ohio State University College of Medicine and has been in practice 39 years. She is experienced in general dermatology and complex medical dermatology.

Education & Training

University of North Carolina HospitalsResidency, Dermatology, 1979 - 1982
University of North Carolina HospitalsInternship, Internal Medicine, 1978 - 1979
Ohio State University College of MedicineClass of 1978

Certifications & Licensure

CA State Medical License 1989 - Present
OH State Medical License 1982 - 2025
AL State Medical License 1999 - 2024
NC State Medical License 1978 - 2002
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Ketoconazole Foam 2% for the Treatment of Versicolor Start of enrollment: 2008 Nov 01
Completed
Phase 4
Can We Miss Pigmented Lesions in Psoriasis Patients? Start of enrollment: 2007 Sep 01
Completed
Phase 4
Epiduo Pediatric Acne Study Start of enrollment: 2010 Jun 01
Completed
Phase 4
Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail Start of enrollment: 2011 Jul 01
Completed
Phase 2
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis Start of enrollment: 2017 Mar 28
Completed
Phase 3
A Proof of Concept Clinical Trial Evaluating the Safety and Efficacy of Eucrisa (Crisaborole) in Patients With Seborrheic Dermatitis Start of enrollment: 2018 Sep 01
Completed
Phase 4
Evaluating the Efficacy and Tolerability of Application of Metaderm Product for the Treatment of Psoriasis Start of enrollment: 2018 Nov 07
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

Letter from the editor: Making sense of central centrifugal cicatricial alopecia (CCCA).
Dirk M Elston, Boni E Elewski, Susan Taylor> ;Journal of the American Academy of Dermatology. 2024 Apr 9
Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal Resistance.
Rachel C Hill, Jeremy A W Gold, Shawn R Lockhart, Dallas J Smith, Avrom S Caplan, Boni Elewski, Shari R Lipner> ;American Journal of Clinical Dermatology. 2024 Mar 18
Treatment Patterns and Negative Health Outcomes in Palmoplantar Pustulosis Patients in Germany and the US.
Alvan Cheng, Xinqing Deng, Fang Yang, Cici Liu, David Neasham, Thomas Kilcoyne, Michael Duxbury, Myriam Cordey, Boni E Elewski> ;Dermatology and Therapy. 2024 Mar 1
Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics.
Faraz Yousefian, Ciaran Smythe, Haowei Han, Boni E Elewski, Mark Nestor> ;The Journal of Clinical and Aesthetic Dermatology. 2024 Mar 1
Calcipotriene/Betamethasone Dipropionate Foam as a Potential Safe and Effective Treatment of Nail Psoriasis.
Abbas, A., Amin, S., Sanyi, A., Mayo, T., Elewski, B.> ;Skin Appendage Disorders. 2024 Feb 1
Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial.
Fiorillo, L., de Lucas, R., Belloni-Fortina, A., Armesto, S., Maes, P., Oberoi, R., Paris, M., Zhang, W., Zhang, Z., Becker, E., Elewski, B., Arkin, L.> ;Journal of the American Academy of Dermatology. 2024 Jan 23
Efficacy of long-term risankizumab treatment for moderate-to-severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestation...
Strober, B., Bachelez, H., Gooderham, M., Menter, A., Strohal, R., Chen, M., Wu, T., Zhan, T., Photowala, H., Crowley, J., Elewski, B., Armstrong, A.> ;Journal of the European Academy of Dermatology and Venereology. 2024 Jan 5
1 citations
Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agents.
Gupta, A., Joseph, W., Daniel, C., Guenin, E., Ghannoum, M., Elewski, B., Lipner, S., Tosti, A.> ;Mycoses. 2024 Jan 1
2 citations
Epigenetic switch reshapes epithelial progenitor cell signatures and drives inflammatory pathogenesis in hidradenitis suppurativa.
Lin Jin, Yunjia Chen, Suhail Muzaffar, Chao Li, Carlos A Mier-Aguilar, Jasim Khan, Mahendra P Kashyap, Shanrun Liu, Ritesh Srivastava, Jessy S Deshane, Tim M Townes, B...> ;Proceedings of the National Academy of Sciences of the United States of America. 2023 Dec 5
Concerning rates of laboratory-confirmed antifungal-resistant onychomycosis and tinea pedis: An online survey of podiatrists, United States.
Kaitlin Benedict, Jeremy A W Gold, Carolynn T Jones, Lisa A Tushla, Shari R Lipner, Warren S Joseph, Dyane E Tower, Boni Elewski, Peter G Pappas> ;Health Science Reports. 2023 Nov 1
2 citations
Generalized pustular psoriasis: A consensus statement from the National Psoriasis Foundation.
April W Armstrong, Carly A Elston, Boni E Elewski, Laura K Ferris, Alice B Gottlieb, Mark G Lebwohl, , Merola, J. F., Merola, J. F., Merola, J. F.> ;Journal of the American Academy of Dermatology. 2024 Apr 1
Mechanism underlying follicular hyperproliferation and oncogenesis in hidradenitis suppurativa.
Lin Jin, Mahendra P Kashyap, Yunjia Chen, Jasim Khan, Yuanyuan Guo, Jari Q Chen, Madison B Lee, Zhiping Weng, Allen Oak, Prasanth Patcha, Tiffany Mayo, Rajesh Sinha, V...> ;Iscience. 2023 Jun 16
Hidradenitis Suppurativa and Five Key Vitamins and Minerals.
Sydney Alexis Weir, Brittany Roman, Victoria Jiminez, Meredith Burns, Adaugo Sanyi, Boni Elewski, Tiffany Mayo> ;Skin Appendage Disorders. 2023 Jun 1
Publisher Correction: Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomise...
Paolo Gisondi, Alice B Gottlieb, Boni Elewski, Matthias Augustin, Sandy McBride, Tsen-Fang Tsai, Christine de la Loge, Frederik Fierens, José M López Pinto, Nicola Til...> ;Dermatology and Therapy. 2023 Jun 1
2 citations
Diversity in the clinical presentation of generalized pustular psoriasis (GPP): A series of case vignettes from around the world.
Siew Eng Choon, Boni E Elewski, Hideki Fujita, Songmei Geng, Peter van de Kerkhof, Sicily Mburu, Lluís Puig, Ricardo Romiti, Marina Venturini> ;Experimental Dermatology. 2023 Aug 1
3 citations
Antifungal Activity of Efinaconazole Compared to Fluconazole, Itraconazole, and Terbinafine against Terbinafine- and Itraconazole-Resistant and -Susceptible Clinical I...
Ahmed Gamal, Mohammed Elshaer, Lisa Long, Thomas S McCormick, Boni Elewski, Mahmoud A Ghannoum> ;Journal of the American Podiatric Medical Association. 2023 Mar 10
The Importance of Screening for Inflammatory Bowel Disease in Patients with Psoriasis and Psoriatic Arthritis.
Isabella Aldana, Vijay Balakrishnan, Boni E Elewski> ;Indian Journal of Dermatology. 2023 Mar 3
5 citations
Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis f...
Boni E Elewski, Mark G Lebwohl, Milan J Anadkat, Jonathan Barker, Kamran Ghoreschi, Shinichi Imafuku, Ulrich Mrowietz, Ling Li, Manuel Quaresma, Christian Thoma, Hervé...> ;Journal of the American Academy of Dermatology. 2023 Jul 1
1 citations
Hair Oils May Worsen Seborrheic Dermatitis in Black Patients.
Tiffany Mayo, Jewell Dinkins, Boni Elewski> ;Skin Appendage Disorders. 2023 Mar 1
Long-Term Health-Related Quality of Life in Patients with Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Randomised Phase 3 Studies (CIM...
Paolo Gisondi, Alice B Gottlieb, Boni Elewski, Matthias Augustin, Sandy McBride, Tsen-Fang Tsai, Christine de la Loge, Frederik Fierens, José M López Pinto, Nicola Til...> ;Dermatology and Therapy. 2023 Jan 1
3 citations
Outcomes of COVID-19 and Vaccination in Patients With Moderate to Severe Atopic Dermatitis Treated With Tralokinumab.
Andrew Blauvelt, Andrew Pink, Margitta Worm, Richard G B Langley, Boni E Elewski, Le Gjerum, Emma Guttman-Yassky> ;JAMA Dermatology. 2022 Nov 1
7 citations
Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat Psoriasis.
Alan Menter, Tina Bhutani, Benjamin Ehst, Boni Elewski, Abby Jacobson> ;Dermatology and Therapy. 2022 Jun 1
5 citations
Seborrheic Dermatitis in Older Adults: Pathogenesis and Treatment Options.
Josiah Sowell, Sandra M Pena, Boni E Elewski> ;Drugs & Aging. 2022 May 1
Vaccine Toes Are the New COVID Toes.
Bonnie Hodge, C Ralph Daniel, Boni Elizabeth Elewski> ;Skin Appendage Disorders. 2022 Apr 28
3 citations
Simultaneous Nail and Skin Clearance in Ixekizumab Head-to-Head Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis.
Boni E Elewski, Andrew Blauvelt, Gaia Gallo, Eric Wolf, Missy McKean-Matthews, Russel Burge, Joseph F Merola, Alice B Gottlieb, Lyn C Guenther> ;Dermatology and Therapy. 2022 Apr 1
Join now to see all

Journal Articles

Association of Secukinumab Treatment with Tuberculosis Reactivation in Patients with Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis
Boni Elewski, MD, JAMA Dermatology

Lectures

Infectious Diseases
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019
Women's & Pediatric Dermatology Seminar 2013
Global Academy for Medical Education (Elsevier), Newport Beach, California - 10/4/2013
Twenty-Second Annual Summer Meeting
West Virginia Dermatologic Society, White Sulphur Springs, West Virginia - 8/24/2012

Press Mentions

Sixty Years of Benzoyl Peroxide Use in DermatologyJanuary 1st, 2023
IL-17 Blockers: Updates on the Safety and Efficacy for PsoriasisOctober 22nd, 2022
A Conversation with Seemal R. Desai, MD, FAADMarch 3rd, 2020
Join now to see all